American Medical Association
FDANonrulemakingFDA-2022-D-0467

Recommendations for Determining Risk of Human Immunodeficiency Virus (HIV) Infection for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Draft Guidance for Industry

RIN
Last modified
Jun 3, 2026
Comment window
closed 537d ago
American Medical Association filings
1

Activity

American Medical Association filed 1 comment on this docket between Feb 11, 2025 and Feb 11, 2025. 0 other organizations filed here. The comment window closed 537d ago.

What American Medical Association filed (1)

Feb 11, 2025· Comment from American Medical Association· FDA-2022-D-0467-0182

Attached please find the American Medical Association's comment in response to Docket FDA-2022-D-0467.

Abstract

No abstract recorded.

View on regulations.gov →